Areas of expertise: Chromatin, post-translational modifications, epigenetics, cancer
Dr. Xiaobing Shi is an expert in cancer epigenetics and a professor in the Center for Epigenetics at Van Andel Institute. He earned a B.S. in biology from Wuhan University followed by a Ph.D. in biology from the Chinese Academy of Sciences, both with honors. He subsequently completed postdoctoral fellowships in the labs of Drs. Arthur Kornberg and Or Gozani at Stanford University before accepting a faculty position at University of Texas MD Anderson Cancer Center, where he most recently served as an Associate Professor and Co-Director of the Center for Cancer Epigenetics. Dr. Shi’s work has led to the discovery of several new readers of histone posttranslational modifications, particularly in acetylation and methylation, and elucidated their impact on cancer development. He is the recipient of several prestigious awards, including a Career Development Award from the Leukemia & Lymphoma Society, a Research Scholar Award from the American Cancer Society, a Kimmel Scholar Award from the Sidney Kimmel Foundation, and an inaugural R. Lee Clark Fellow from UT M.D. Anderson Cancer Center.